ArticleProgress in pediatric cardiology2014

Patient-Specific Pluripotent Stem Cells in Doxorubicin Cardiotoxicity: A New Window Into Personalized Medicine.

Daniel Bernstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.